METgene amplification orEGFRmutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

METgene amplification orEGFRmutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

Published:2009-04-15 Issue:8 Volume:124 Page:1778-1784
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kubo Takafumi,Yamamoto Hiromasa,Lockwood William W.,Valencia Ilse,Soh Junichi,Peyton Michael,Jida Masaru,Otani Hiroki,Fujii Tetsuya,Ouchida Mamoru,Takigawa Nagio,Kiura Katsuyuki,Shimizu Kenji,Date Hiroshi,Minna John D.,Varella-Garcia Marileila,Lam Wan L.,Gazdar Adi F.,Toyooka Shinichi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Somatic alterations in the human cancer genome;Weir;Cancer Cell,2004

2. Lung cancer: intragenic ERBB2 kinase mutations in tumours;Stephens;Nature,2004

3. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas;Shigematsu;Cancer Res,2005

4. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplexed In Vivo Screening Using Barcoded Aptamer Technology to Identify Oligonucleotide-Based Targeting Reagents;Nucleic Acid Therapeutics;2024-06-01

2. Phytochemical composition of the diethyl ether extract of Artemisia lactiflora Wall. ex DC and its antimetastatic activity in human lung cancer cells;Natural Product Research;2024-03-05

3. Characterizing the secretome of EGFR mutant lung adenocarcinoma;Frontiers in Oncology;2024-01-08

4. A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib;Therapeutic Advances in Medical Oncology;2024-01

5. Paeoniae Radix Overcomes Resistance to Egfr-Tkis Via Aurora B Pathway Suppression in Non-Small Cell Lung Cancer;2024